Tumor Necrosis Factor Receptor Superfamily Member 19l Amount
Introduction
Background
TNFRSF19L (Tumor Necrosis Factor Receptor Superfamily Member 19L), also known as TROY, is a protein that belongs to the tumor necrosis factor receptor superfamily. This family of receptors plays a critical role in regulating various cellular processes, including cell survival, proliferation, and differentiation. TNFRSF19L itself is involved in diverse biological functions, particularly in neural development and the regulation of cell death pathways.
Biological Basis
The amount of TNFRSF19L protein present in an individual, referred to as TNFRSF19L amount, is a quantitative trait influenced by genetic and environmental factors. Genetic variations, such as single nucleotide polymorphisms (SNPs), can act as protein quantitative trait loci (pQTLs). These pQTLs can affect the expression, synthesis, stability, or degradation of a protein, thereby influencing its circulating levels. Studies have demonstrated that genetic factors significantly determine the levels of various proteins in the bloodstream. [1]
Methodological and Statistical Constraints
Studies often face limitations in detecting associations, particularly for less frequent genetic variants or those with small effect sizes. While large cohorts provide substantial power for common variants, the ability to identify rarer variants, even with comparable or larger effects, remains challenging ([2] ). Furthermore, the reported effect sizes for the most strongly associated single nucleotide polymorphisms (SNPs) may be overestimates of their true effects, a phenomenon known as effect-size inflation, which can occur when selecting the SNP with the smallest p-value at a locus ([3] ).
Not all SNPs are directly genotyped, and the quality of imputation can vary, leading to reduced statistical power for poorly imputed markers ([3] ). The identified lead SNP, while having the strongest statistical association, may not be the actual causal variant, and its effect size might not precisely reflect the true biological impact ([3] ). Additionally, in regions where genes clustered and variants are in high linkage disequilibrium (LD), distinguishing truly independent associations from those driven by known causal variants can be difficult, potentially obscuring novel genetic signals ([3] ). The reliance on an additive genetic model for association testing also means that other genetic architectures, such as dominant or recessive modes of inheritance, might be overlooked, potentially missing important associations ([1] ).
Phenotypic Characterization and Measurement Challenges
The quantification of tumor necrosis factor receptor superfamily member 19l amount can be influenced by factors beyond true biological concentration. For instance, non-synonymous SNPs could alter the binding affinity of antibodies used in assays, leading to an apparent change in protein levels that is a measurement artifact rather than a genuine shift in protein abundance ([1] ). Moreover, the relevance of the tissue used for gene expression analysis, such as unstimulated cultured lymphocytes, may not always accurately reflect protein levels or their functional implications in target tissues, especially for dynamic proteins like inflammatory cytokines that respond to specific stimuli ([1] ).
Challenges also arise from the handling of trait distributions, particularly when a significant proportion of samples fall below detectable limits. In such cases, dichotomizing a continuous trait, for example, at a median or clinical cutoff, can lead to a loss of valuable quantitative information and reduced statistical power ([1] ). This approach simplifies the trait but may not fully capture the biological nuances of tumor necrosis factor receptor superfamily member 19l amount across its full range. Furthermore, the correlation between gene expression levels and protein abundance is known to exhibit considerable variation across different biological contexts, indicating that genetic influences on mRNA may not always translate directly to protein levels ([1] ).
Generalizability and Unaccounted Biological Complexity
Many large-scale genetic association studies, including those informing our understanding of tumor necrosis factor receptor superfamily member 19l amount, are predominantly conducted in populations of specific ancestries, such as individuals of European descent ([4] ). This limits the generalizability of findings to other diverse populations and underscores the need for broader representation to identify population-specific variants or confirm universal effects. While efforts are typically made to control for population stratification and cryptic relatedness, these factors can still subtly influence association results and potentially inflate statistical significance ([5] ).
Despite the identification of numerous genetic loci, the variants discovered often explain only a modest proportion of the overall variability in traits like tumor necrosis factor receptor superfamily member 19l amount ([6] ). This "missing heritability" suggests that a substantial portion of genetic influence remains undiscovered, possibly attributable to unmeasured rare variants, complex gene-gene or gene-environment interactions, or structural genomic variations like copy number variants (CNVs) that are not fully captured by standard SNP arrays ([1] ). Furthermore, for many identified associations, the precise biological mechanism linking the genetic variant to the altered protein level remains unknown, necessitating further functional studies to fully elucidate the pathways involved ([1] ).
Variants
Genetic variations play a crucial role in modulating immune responses and influencing levels of inflammatory mediators such as tumor necrosis factor alpha (TNF-alpha). Variants within genes related to the immune system, cellular signaling, and metabolic pathways can alter protein function or expression, thereby affecting the body's inflammatory state. For instance, the CFH gene, or Complement Factor H, is a key regulator of the complement system, a part of the innate immune response, and the rs203688 variant within this gene may influence its regulatory activity, impacting the body's ability to control inflammation. Polymorphisms in CFH have been linked to immune-related conditions, such as age-related macular degeneration, highlighting its broad importance in immune regulation. [7] Similarly, RELT (Receptor Expressed in Lymphoid Tissues) is a member of the TNF receptor superfamily, and variants like rs151264098 and rs56801796 could modify its function, directly affecting immune cell activation and signaling pathways that involve TNF-alpha. Moreover, the rs3184504 variant, located near both ATXN2 (Ataxin 2) and SH2B3 (SH2B Adaptor Protein 3), is particularly relevant given SH2B3's role as an adaptor protein in cytokine signaling, which is critical for immune cell function and can influence a wide range of inflammatory processes, including those involving TNF-alpha. The ABO blood group, for example, has been associated with TNF-alpha levels, demonstrating how genetic factors can broadly influence inflammatory protein levels. [1]
Other variants influence fundamental cellular processes that indirectly contribute to inflammation. The rs7933162 variant in ARHGEF17 (Rho Guanine Nucleotide Exchange Factor 17) may impact the regulation of Rho GTPases, which are essential for cell cytoskeleton organization, migration, and proliferation—processes vital for immune cell movement and function during inflammation. Changes in these cellular dynamics can alter how immune cells respond to stimuli and produce cytokines. Variants such as rs7952686, rs78975595, and rs113988287 in FAM168A (Family With Sequence Similarity 168 Member A), a gene implicated in cell proliferation and programmed cell death, could affect cellular turnover and tissue repair mechanisms, which are closely intertwined with inflammatory responses. Furthermore, the rs542623840 variant, found in the region between PLEKHB1 (Pleckstrin Homology Domain Containing B1) and RAB6A (RAB6A, Member RAS Oncogene Family), could influence intracellular protein transport and signaling pathways. RAB6A, a small GTPase, is crucial for Golgi apparatus-mediated trafficking, and alterations here might impact the secretion of various proteins, including inflammatory cytokines, thereby modulating systemic inflammation. Studies have identified numerous genetic associations with various biomarker traits, emphasizing the widespread influence of genetic variants on biological processes . [1], [6]
Variants affecting organ function and metabolic pathways can also have systemic effects on inflammation. For instance, the rs28418670 variant in SHROOM3 (Shroom Family Member 3) and rs77924615 in PDILT (Protein Disulfide Isomerase Like, Testis Expressed) are associated with kidney function. SHROOM3 plays a role in kidney development and morphology, while PDILT is involved in protein folding within the endoplasmic reticulum. Dysregulation in renal function can lead to an accumulation of inflammatory mediators and contribute to chronic systemic inflammation, which can influence TNF-alpha levels . [8] The rs190011892 variant in MRPL48 (Mitochondrial Ribosomal Protein L48) impacts mitochondrial ribosomal function. Healthy mitochondrial activity is vital for cellular energy production and can modulate immune cell activation and inflammatory signaling. Lastly, the rs11447348 variant, located near LINC01322 (Long Intergenic Non-Protein Coding RNA 1322) and BCHE (Butyrylcholinesterase), may influence metabolic processes. BCHE is an enzyme involved in hydrolyzing choline esters and is linked to lipid metabolism and detoxification, pathways that can have significant indirect effects on inflammatory status and the production of cytokines like TNF-alpha.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs203688 | CFH | serum albumin amount interleukin-17A measurement protein measurement colipase-like protein 2 measurement tumor necrosis factor receptor superfamily member 19l amount |
| rs7952686 rs78975595 rs113988287 |
FAM168A | tumor necrosis factor receptor superfamily member 19l amount |
| rs151264098 rs56801796 |
RELT | tumor necrosis factor receptor superfamily member 19l amount |
| rs7933162 | ARHGEF17 | tumor necrosis factor receptor superfamily member 19l amount |
| rs3184504 | ATXN2, SH2B3 | beta-2 microglobulin measurement hemoglobin measurement lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma platelet crit coronary artery disease |
| rs542623840 | PLEKHB1 - RAB6A | tumor necrosis factor receptor superfamily member 19l amount |
| rs28418670 | SHROOM3 | collagen alpha-3(VI) chain measurement tumor necrosis factor receptor superfamily member 19l amount |
| rs77924615 | PDILT | glomerular filtration rate chronic kidney disease blood urea nitrogen amount serum creatinine amount protein measurement |
| rs190011892 | MRPL48 | tumor necrosis factor receptor superfamily member 19l amount |
| rs11447348 | LINC01322, BCHE | transmembrane protein 59-like measurement ADP-ribosylation factor-like protein 11 measurement biglycan measurement protein TMEPAI measurement histone-lysine n-methyltransferase EHMT2 measurement |
Biological Background
(No information on 'tumor necrosis factor receptor superfamily member 19l amount' is available in the provided context.)
Immune and Inflammatory Signaling Pathways
Many immune and inflammatory processes are orchestrated through the precise signaling of cytokines and chemokines. For instance, alveolar macrophages, upon activation by IgE receptors, produce a diverse array of chemokines alongside both pro-inflammatory and anti-inflammatory cytokines, initiating complex cellular responses. Key inflammatory mediators such as TNF-alpha and IL-6 are subject to genetic and biological variations influencing their concentrations, impacting the intensity and duration of inflammatory cascades. Furthermore, the carboxypeptidase N enzyme acts as a pleiotropic regulator of inflammation, modulating the activity of various peptides involved in immune responses. [6]
The regulation of immune responses extends to intricate genetic controls, as demonstrated by mutant collagen XIII altering intestinal expression of immune response genes, leading to predisposition to B-cell lymphomas. Chemokines, such as those encoded by the CCL3L1 gene and the CCL18-CCL3-CCL4 cluster, play a critical role in immune cell trafficking and influence susceptibility to and progression of diseases like HIV-1/AIDS. Additionally, CCL2 polymorphisms are associated with monocyte chemoattractant protein-1 levels, linking chemokine signaling to cardiovascular events like myocardial infarction. Signaling through cytokine receptors, like the IL6 receptor (IL6R), is integral to inflammatory responses, influencing levels of C-reactive protein and contributing to metabolic syndrome pathways. [9] Caspase activation, often a downstream effector of receptor signaling, is also noted in contexts like renal development, highlighting its role in programmed cell death and tissue remodeling. [10]
Metabolic Control and Energy Homeostasis
Metabolic pathways are fundamental to cellular energy balance and nutrient processing, with enzymes like glucokinase playing a critical role in glucose phosphorylation and subsequent metabolic flux, particularly in response to varying glucose levels. Energy homeostasis is rigorously maintained by systems such as the AMP-activated protein kinase, where mutations in its gamma[6] subunit can compromise cellular energy leading to severe conditions like familial hypertrophic cardiomyopathy. Beyond glucose, lipid metabolism is equally vital; for example, triglyceride biosynthesis in hepatocytes can be suppressed by squalene synthase inhibitors acting on the farnesol pathway, highlighting specific regulatory points in lipid synthesis. Amino acid metabolism is also crucial, with enzymes like cytosolic branched-chain aminotransferase 1 (BCAT1) involved in processing branched-chain amino acids. [11]
Genetic variations significantly influence metabolic regulation and disease susceptibility. For instance, a polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels, indicating its role in glucose control. Similarly, variants near MTNR1B are linked to increased fasting plasma glucose and an elevated risk of type 2 diabetes. The intricate interplay between metabolic and inflammatory pathways is evident in the interaction between variants in the PPARG and IL-6 genes, which collectively contribute to obesity-related metabolic risk factors. This demonstrates how dysregulation within these interconnected metabolic and inflammatory networks can culminate in conditions such as metabolic syndrome, where factors like C-reactive protein are implicated. [12]
Cellular Communication and Transcriptional Regulation
Cellular communication is critically mediated by diverse signaling pathways, initiated by receptor activation at the cell surface. For instance, vascular endothelial growth factor (VEGF) induces branching morphogenesis and tubulogenesis in renal epithelial cells through a neuropilin-dependent mechanism, demonstrating a key role in tissue development and structural organization. This VEGF-A signaling pathway also exhibits crosstalk within the glomerulus, integrating signals between components of the glomerular filtration barrier. Similarly, transforming growth factor-beta (TGF-beta) activity is modulated by fatty acids, influencing its plasma clearance and implying a regulatory link between lipid metabolism and growth factor signaling. Intracellularly, molecules like RAP1, a GTP-GDP dissociation stimulator, participate in complex signaling cascades, regulating diverse cellular functions from cell adhesion to proliferation. [13]
Transcriptional regulation forms the bedrock of cellular identity and function, with gene expression being influenced by a myriad of factors including transcription factors and nuclear receptors. Nuclear receptor subfamily 3, group C, member 2 (NR3C2) exemplifies such regulation, controlling gene expression in response to specific ligands. Large-scale transcriptional profiling and genome-wide association studies have identified expression quantitative trait loci (eQTLs) that significantly influence global gene expression patterns in various cell types, including human lymphocytes, revealing a hierarchical layer of genetic control over mRNA levels. The integration of these pathways is highlighted by instances of pathway crosstalk, such as the allele affecting both soluble IL-6 receptor and IL-6 levels, demonstrating how a single genetic variant can impact multiple interconnected components of a signaling network and influence overall systemic responses. [14]
Systems-Level Pathway Integration and Disease Pathogenesis
Biological systems are characterized by intricate pathway crosstalk and network interactions, where the dysregulation of one pathway can have cascading effects across multiple systems, contributing to disease pathogenesis. For example, the interplay between metabolic and inflammatory pathways is crucial in conditions like metabolic syndrome, where variants in genes such as LEPR, HNF1A, IL6R, and GCKR are associated with plasma C-reactive protein levels, an inflammatory marker. This highlights how genetic predisposition can influence the integrated metabolic-inflammatory axis. Similarly, the regulation of vascular endothelial growth factor (VEGF)-A signaling in the glomerulus demonstrates crosstalk between components of the glomerular filtration barrier, emphasizing the complex network required for maintaining organ function. [13]
Hierarchical regulation governs many biological processes, from global gene expression patterns, as revealed by expression quantitative trait loci (eQTLs) identified through transcriptional profiling, to the coordinated control of cytokine loci. The Th2 cytokine locus, for instance, is under the control of a locus control region, illustrating how higher-order genomic elements dictate immune responses. The emergent properties of these complex networks are often observed in disease states; mutations in the AMP-activated protein kinase, leading to familial hypertrophic cardiomyopathy, underscore how fundamental energy compromise can manifest as severe organ dysfunction. Understanding these integrated mechanisms, including the roles of TNF-alpha, IL-6, and chemokines, not only elucidates disease etiology but also identifies potential therapeutic targets, such as squalene synthase inhibitors for lipid biosynthesis or modulators of inflammatory pathways. [11]
Frequently Asked Questions About Tumor Necrosis Factor Receptor Superfamily Member 19L Amount
These questions address the most important and specific aspects of tumor necrosis factor receptor superfamily member 19l amount based on current genetic research.
1. Why is my protein amount different from my family's?
Your protein amount is a complex trait influenced by both your unique genetic makeup and environmental factors. While you share many genes with your family, variations in these genes and individual life experiences can lead to differences in your specific protein levels. Research consistently shows that genetic factors play a significant role in determining protein amounts in the bloodstream.
2. Can my daily habits change my protein amount?
Yes, environmental factors, which encompass your daily habits and lifestyle, can influence your protein amount. Your genetic blueprint provides a foundational range, but external influences can modulate the actual levels of this protein in your body. However, the specific impact of particular habits on this protein's amount isn't fully understood yet.
3. Does my ethnic background affect my protein amount?
Your ethnic background can indeed play a role. Many large-scale genetic studies are predominantly conducted in populations of specific ancestries, such as those of European descent. This means that genetic variants influencing protein amounts might differ across diverse populations, highlighting the importance of broader representation in research to identify population-specific effects.
4. Is it true my DNA can predict my protein amount?
Yes, genetic variations like single nucleotide polymorphisms (SNPs) can act as protein quantitative trait loci (pQTLs) that influence your protein amount. These genetic markers can affect how much protein is expressed, synthesized, or degraded, thereby impacting its circulating levels. However, genes often explain only a portion of the total variation, and environmental factors also contribute significantly.
5. Why don't we know everything about what affects my protein amount?
Understanding complex traits like your protein amount is an ongoing challenge. A substantial portion of genetic influence, often called "missing heritability," remains undiscovered, possibly due to unmeasured rare variants, complex gene-gene interactions, or other genomic variations. Furthermore, for many identified genetic associations, the precise biological mechanism linking the variant to altered protein levels is still unknown, requiring further functional studies.
6. Could my measured protein amount be inaccurate sometimes?
Yes, it's possible for measurement artifacts to occur. For example, non-synonymous genetic variations in your protein could alter the binding affinity of antibodies used in laboratory assays. This might lead to an apparent change in protein levels that is a measurement issue rather than a genuine shift in the actual protein abundance in your body.
7. Does stress or sleep affect my protein amount?
While specific research on how stress or sleep directly impacts this particular protein amount isn't detailed, protein levels are generally influenced by environmental factors. Dynamic proteins, especially those involved in cellular processes like this one, can respond to various stimuli. More dedicated studies are needed to fully understand the effects of daily stressors or sleep patterns on your protein amount.
8. If my parents have high levels, will I inherit that?
You might, as genetic factors significantly determine protein levels, and you inherit genes from your parents. However, your protein amount is a complex quantitative trait influenced by many genetic variants, not just one. Your unique environmental exposures also play a crucial role, meaning it's not a simple, direct inheritance pattern.
9. Why is it hard to measure my protein amount accurately sometimes?
Accurate quantification can be challenging, especially when a significant proportion of samples have protein levels below detectable limits. In such cases, researchers might have to simplify the data, which can lead to a loss of valuable quantitative information and reduce the statistical power to uncover nuances in your protein amount across its full range.
10. Can a DNA test tell me my exact risk for my protein amount?
While genetic tests can identify lead genetic variants statistically associated with protein levels, these might not always be the actual causal variants. Additionally, reported effect sizes for the strongest associations can sometimes be overestimates of their true biological impact. Such tests provide valuable insights but don't capture all the complex genetic and environmental factors influencing your exact protein amount.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Melzer, D., et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genet, vol. 4, no. 5, 2008, p. e1000072.
[2] Xing, Chun et al. "A weighted false discovery rate control procedure reveals alleles at FOXA2 that influence fasting glucose levels." American Journal of Human Genetics, 2010.
[3] Smith, N. L. et al. "Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium." Circulation, 2010.
[4] Sun, Qi et al. "Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels." Human Molecular Genetics, 2010.
[5] Lowe, Jennifer K. et al. "Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae." PLoS Genetics, 2009.
[6] Benjamin, Emelia J. et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, 2007.
[7] Chalasani, Naga, et al. "Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease." Gastroenterology, vol. 139, no. 5, 2010, pp. 1567-1576.e3.
[8] Kottgen, Anna, et al. "New loci associated with kidney function and chronic kidney disease." Nature Genetics 42.5 (2010): 376-381.
[9] Gonzalez, Elena, et al. "The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility." Science 307.5714 (2005): 1434-1440.
[10] Hayashi, Masayuki. "Caspase in renal development." Nephrology Dialysis Transplantation 17.suppl 9 (2002): 8-10.
[11] Blair, Edward, et al. "Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis." Human Molecular Genetics 10.12 (2001): 1215-1220.
[12] Barbieri, Maurizio, et al. "Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors." Experimental Gerontology 40.7 (2005): 599-604.
[13] Eremina, Victoria, et al. "Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier." Nephron Physiology 106.2 (2007): p32-p37.
[14] Dixon, Amy L., et al. "A genome-wide association study of global gene expression." Nature Genetics 39.10 (2007): 1202-1207.